Navigation Links
Gel Offers A More Targeted Approach

Patients with diabetes, Crohn's disease, bowel cancer, constipation and other conditions may soon be able to take their medication orally instead of using injections.Scientists in India have developed a new oral gel that is able to deliver // drugs to manage diseases that often require an injection such as ulcerative colitis and some infections.

The new gel can also prevent problems caused by other medications. While other drugs can sometimes be toxic and ineffective, the gel gives a targeted, controlled release of the medication.The hydrogel system has been designed so that when it's swallowed, it's protected from stomach acid. When the drug passes through the stomach, it retains the majority of the medication by being protected from stomach acids. More than half of the medication is released where it is needed -- further down the gastrointestinal tract in the colon.

Researchers put vitamin B2 in the hydrogel instead of a drug and studied its release in conditions simulating a human body. However they say the next step is to conduct in vivo studies of the hydrogel system so it can be modified to produce oral pills.
'"/>




Page: 1

Related medicine news :

1. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
2. Drug Offers Hope for Alzheimers disease
3. Drug Firm Offers to Donate Smallpox Vaccine
4. fMRI Offers Insight Into An Infants Brain
5. Umbilical Cord Blood Offers Hope For Patients Who Require Bone Marrow Transplants
6. Surgery Offers Better Treatment For Third Degree Piles
7. New Study Offers Hope For Balding Men
8. Gamma Knife Offers New Hope For Trigeminal Neuralgia Patients
9. Study Offers Insights Into Treatment Of Rheumatoid Arthritis
10. CPHA Offers HIV Information Packages To Canadian Football League Teams
11. Blair Offers James Support To Fight AIDS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... ... People are starting to accept that hearing aids can be helpful and ... it had when great-grandpa wore his hearing aids years ago,” said Dr. Maura Marks, ... American Speaker Series (NASS) segment. “He probably wore an iPod-size hearing aid on ...
(Date:4/28/2017)... Pensacola, FL (PRWEB) , ... April 28, 2017 ... ... Tampa, Florida are conducting a pilot study of ActiGraph’s CentrePoint Data ... ActiGraph is a leading provider of clinical-grade wearable activity and sleep monitoring solutions ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a ... its Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, ... power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Semrock’s ... is the premier online modeling resource for fluorescence microscopists and optical system designers, ... during last 5 years spanning the globe, SearchLight has become a tremendously popular ...
(Date:4/27/2017)... DC (PRWEB) , ... April 27, 2017 , ... ... Behavioral Economics Insights in Incentives, Rewards, and Recognition: A Nudge Guide," a groundbreaking ... recognition (IRR) field. Offering practical takeaways to apply immediately to IRR programs, the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... MOUNTAIN VIEW, Calif. , April 19, 2017 /PRNewswire/ ... that it will release financial results for the first ... May 3, 2017.  The Company,s management team will host ... / 5:30 p.m. ET. Investors interested in ... dialing (844) 707-0665 for domestic callers or (703) 326-3030 ...
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market ... has covered and analysed the potential of Global Effective Microorganisms ... shares and growth factors. The report identifies and analyses the ... the global market. ... 152 Tables and Figures, 6 Major Company Profiles, spread across ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
Breaking Medicine Technology: